View printer-friendly version

Download PDF

Emergent BioSolutions to Release Third Quarter 2014 Financial Results and Conduct a Conference Call on November 6, 2014

ROCKVILLE, Md.–(BUSINESS WIRE)–Oct. 9, 2014– Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call at 5:00 pm (Eastern Time) on Thursday, November 6, 2014. The call will last approximately 1 hour.

During the call, company management will discuss the financial results for the third quarter and first nine months of 2014, recent business developments and revenue and net income guidance for full year 2014.

This conference call can be accessed live by telephone or through Emergent’s website:

Live Teleconference Information:
Dial in number: 888-713-4205
(International dial in: 617-213-4862)
Passcode: 62434264

Live Webcast Information:
Visit www.emergentbiosolutions.com
and select the “Investors” section

Pre-registering for the live call will expedite access and minimize hold times. You will be issued a passcode to bypass the operator and connect directly. To pre-register for the call, visit the following website: https://www.theconferencingservice.com/prereg/key.process?key=PFN984X9C

Telephonic Replay Information:
Dial in number: 888-286-8010
(International dial in: 617-801-6888)
Passcode: 49407730
Available 9:00PM (Eastern Time)
November 6, 2014 through November 20, 2014

Webcast Archive:

Visit www.emergentbiosolutions.com
and select the “Investors” section
Available through November 5, 2015

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.About Emergent BioSolutions Inc.

Follow us on twitter: @emergentbiosolu.